• Part 1 consists of a 2 hour eLearning component introducing the learner to assessment, management and treatment of hepatitis C in drug and alcohol settings.
• Part 2 consists of an interactive face-to-face workshop building on the knowledge and skills gained in Part 1 through practical case discussions and simulation-based models.
• Part 3 consists of a tailored capacity strengthening toolkit including: a checklist for the assessment and treatment of HCV in drug and alcohol settings; local referral pathways; Fibroscan® access forms; assessment pro forma; and quick reference guides.
Learning outcomes•Describe the risk factors for HCV infection enabling effective screening and prevention education
•Demonstrate competence conducting and interpreting tests to diagnose HCV
•Recognise risk factors, clinical signs, symptoms and complications of liver disease
•Demonstrate understanding of DAA therapy for the treatment of HCV and competence in selecting appropriate therapy
•Describe recommended on-treatment monitoring and post-treatment follow up protocols
Drug and Alcohol Nurse Practitioners, Drug and Alcohol Nurse Practitioner Candidates, other Nurse Practitioners (I.e. Primary Care, hepatology etc)
Morning Tea, Lunch and Afternoon Tea to be provided.
Storey Hall, RMIT University
336-348 Swanston Street